Evidence map›Paper›PMID 38731943›Full record

ReviewInternational journal of molecular sciences2024

Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases.

Swapnil P Bhujbal, Joonhong Jun, Haebeen Park, Jihyun Moon, Kyungbae Min, Jung-Mi Hah

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Discovery of 2H-Pyrrolo[3,4‑ACS medicinal chemistry letters · 2026
    Article
  4. Review
  5. Conformational dynamics in insulin receptor kinase reveal a type III allosteric pocket.Protein science : a publication of the Protein Society · 2026
    Article
  6. Drug design for cyclin-dependent kinase 9 (CDK9) inhibitorsBiochemistry and biophysics reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Swapnil P BhujbalCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Joonhong JunCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Haebeen ParkCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Jihyun MoonCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Kyungbae MinCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Jung-Mi HahCollege of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.ORCID 0000-0001-6439-0405

Funding

National Research Foundation of Korea NRF-2020R1A6A1A03042854 (Center for Proteinopathy), NRF-2021R1A2C2007159 (J.-M.Hah)
6 · The paper itself

Abstract

Protein kinases are essential regulators of cell function and represent one of the largest and most diverse protein families. They are particularly influential in signal transduction and coordinating complex processes like the cell cycle. Out of the 518 human protein kinases identified, 478 are part of a single superfamily sharing catalytic domains that are related in sequence. The dysregulation of protein kinases due to certain mutations has been associated with various diseases, including cancer. Although most of the protein kinase inhibitors identified as type I or type II primarily target the ATP-binding pockets of kinases, the structural and sequential resemblances among these pockets pose a significant challenge for selective inhibition. Therefore, targeting allosteric pockets that are beside highly conserved ATP pockets has emerged as a promising strategy to prevail current limitations, such as poor selectivity and drug resistance. In this article, we compared the binding pockets of various protein kinases for which allosteric (type III) inhibitors have already been developed. Additionally, understanding the structure and shape of existing ligands could aid in identifying key interaction sites within the allosteric pockets of kinases. This comprehensive review aims to facilitate the design of more effective and selective allosteric inhibitors.

Indexed as

Allosteric SiteProtein Kinase InhibitorsProtein KinasesAdenosine TriphosphateAllosteric RegulationBinding SitesCatalytic DomainHumansLigandsModels, MolecularProtein BindingAdenosine TriphosphateLigandsProtein Kinase InhibitorsProtein Kinasesallostericcancerprotein kinasetype III inhibitors

Identifiers

PMID38731943
PMCPMC11084947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.